Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | LARP6 |
| Upstream (Parents) |
|---|
| (<<) ANKDD1A → LARP6 |
| (<<) ANXA2 → LARP6 |
| (<<) BMP2 → LARP6 |
| (<<) CASP8 → LARP6 |
| (<<) CCNA1 → LARP6 |
| (<<) CD83 → LARP6 |
| (<<) CEBPB → LARP6 |
| (<<) CSNK1A1 → LARP6 |
| (<<) CXCL3 → LARP6 |
| (<<) CYB5R3 → LARP6 |
| (<<) DAZAP2 → LARP6 |
| (<<) DEPDC7 → LARP6 |
| (<<) E2F6 → LARP6 |
| (<<) GNG5 → LARP6 |
| (<<) HDAC8 → LARP6 |
| (<<) IL1R2 → LARP6 |
| (<<) MAP2K1 → LARP6 |
| (<<) MLPH → LARP6 |
| (<<) NAGS → LARP6 |
| (<<) PITPNA → LARP6 |
| (<<) PRKCDBP → LARP6 |
| (<<) PRSS2 → LARP6 |
| (<<) RNASE4 → LARP6 |
| (<<) SAA4 → LARP6 |
| (<<) SESN1 → LARP6 |
| (<<) SH3KBP1 → LARP6 |
| (<<) SOCS1 → LARP6 |
| (<<) ST3GAL6 → LARP6 |
| (<<) TNF → LARP6 |
| (<<) UBE2E3 → LARP6 |
| (<<) UBE2N → LARP6 |
| (<<) VCP → LARP6 |
| (<<) WNT5B → LARP6 |
| Downstream (Children) |
|---|
| LARP6 → CALB1 (>>) |
| LARP6 → CHST2 (>>) |
| LARP6 → FGFBP1 (>>) |
| LARP6 → FUT1 (>>) |
| LARP6 → MEX3B (>>) |
| LARP6 → NXT1 (>>) |
| LARP6 → PRKCA (>>) |
| LARP6 → SMAD7 (>>) |
